Mutations in SLC4A11 are considered responsible for human corneal disorders, such as autosomal recessive congenital hereditary endothelial dystrophy (CHED2) (Jiao et al. 2007; Hand et al. 2017), Harboyan syndrome (Desir and Abramowicz 2008; Liskova et al. 2015; Siddiqui et al. 2014) and Fuchs endothelial corneal dystrophy (Vithana et al. 2008; Kim et al. 2015). Here, SLC4A11 is linked to Fuchs endothelial corneal dystrophy.